5 Recruiting Generalized Myasthenia Gravis Phase 2 Clinical Trials

Active phase 2 studies for generalized myasthenia gravis enrolling across the USA. Verify eligibility and contact site coordinators.

All Generalized Myasthenia Gravis studies

Phase 2 Studies for Generalized Myasthenia Gravis

🟢 Recruiting Phase1 / Phase2

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

📍 Univ Cali Irvine ALS Neuromuscular — Orange, California

View Study & Checklist ➔

🟢 Recruiting Phase2

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

📍 Austin Neuromuscular Center — Austin, Texas

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

📍 Mg0014 50168 — Chicago, Illinois

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

📍 Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital — Chicago, Illinois

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

📍 Carolinas HealthCare System Neurosciences Institute - Neurology — Charlotte, North Carolina

View Study & Checklist ➔